Loading…
Loading…
Is this mostly mass spec? Is it cryo EM? Any particular segments that are emerging
would love a little bit more color on the contract research side of the house
is there any reason that the CRO business isn't back to more normalized, call it, high single-digit growth
Can you maybe talk about the opportunity set there, how you feel about current capacity in fill-finish today
anything around order growth? Is this mostly share gains from your perspective? Much of this is bundling
I didn't actually hear what you're assuming for China growth this year. Assuming your products come off the trade restrictions list
trying to understand why now is the right time. Synergies for PPD have gone well. So any kind of bogey you can point to